What deficiency results in sialidosis?

Prepare for the NBME Form 27 Test. Practice with extensive flashcards and multiple-choice questions that include helpful hints and detailed explanations. Ensure success on your exam!

Multiple Choice

What deficiency results in sialidosis?

Explanation:
Sialidosis is a lysosomal storage disorder caused by a deficiency in neuraminidase, which is responsible for the hydrolysis of sialic acid residues from glycoproteins and glycolipids. This enzymatic deficiency leads to the accumulation of sialylated oligosaccharides in various tissues, particularly affecting the central nervous system, and results in neurological deficits along with other clinical manifestations. The condition is characterized by symptoms such as developmental delays, ataxia, and ocular symptoms, including cherry-red spots on the macula. The accumulation of sialylated compounds is significant in developing the clinical features associated with sialidosis. In this scenario, focusing on the role of neuraminidase highlights the biochemical pathways disrupted by its deficiency, specifically the metabolism of sialic acid, contributing to the clinical picture of the disorder. This understanding is crucial for recognizing the specific enzymatic deficiencies and their corresponding disorders within the lysosomal storage diseases.

Sialidosis is a lysosomal storage disorder caused by a deficiency in neuraminidase, which is responsible for the hydrolysis of sialic acid residues from glycoproteins and glycolipids. This enzymatic deficiency leads to the accumulation of sialylated oligosaccharides in various tissues, particularly affecting the central nervous system, and results in neurological deficits along with other clinical manifestations.

The condition is characterized by symptoms such as developmental delays, ataxia, and ocular symptoms, including cherry-red spots on the macula. The accumulation of sialylated compounds is significant in developing the clinical features associated with sialidosis.

In this scenario, focusing on the role of neuraminidase highlights the biochemical pathways disrupted by its deficiency, specifically the metabolism of sialic acid, contributing to the clinical picture of the disorder. This understanding is crucial for recognizing the specific enzymatic deficiencies and their corresponding disorders within the lysosomal storage diseases.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy